COOPER COMPANIES, INC.

COO 10-K · Q4 2025

COO Q4 2025 request

Playground key active
Request URL /api/financials?ticker=COO&year=2025&quarter=4
waiting 0 ms
Pick an endpoint and run the request.
curl

Income Statement

Income Statement
Metric Q4 2025 Q4 2024 YoY
Revenue 1,065.1 1,018.4 +4.6%
Show Product Lines breakouts
Fertility · Coopersurgical Segment 140.9 139.2 +1.2%
Office and surgical · Coopersurgical Segment 214.5 202.8 +5.8%
Sphere, other · Coopervision Segment 365 353.2 +3.3%
Toric and multifocal · Coopervision Segment 344.7 323.2 +6.7%
Show Business Segments breakouts
Coopersurgical Segment · Operating Segments 355.4 342 +3.9%
Coopervision Segment · Operating Segments 709.7 676.4 +4.9%
Show Geography breakouts
Europe 330.7 305.6 +8.2%
US 526.2 505.3 +4.1%
Show — breakouts
Revenue 208.2 207.5 +0.3%
Cost of Revenue 414.3 340.7 +21.6%
Gross Profit 650.8 677.7 -4.0%
Selling, General & Administrative 419.2 391.4 +7.1%
Research & Development 41.4 37.7 +9.8%
Amortization Of Intangible Assets 49.8 50.2 -0.8%
Operating Income 140.4 198.4 -29.2%
Show — breakouts
Operating Income 3.7 31.4 -88.2%
Operating Income 689.9 589.3 +17.1%
Show Consolidation Items breakouts
Corporate Non Segment -20 -21.5 +7.0%
Interest Expense 24.4 27 -9.6%
Other Non-Operating Income (Expense) -0.8 2.8 -128.6%
Income Before Taxes 116.8 168.6 -30.7%
Income Tax Expense (Benefit) 32.2 51.1 -37.0%
Net Income 84.6 117.5 -28.0%
EPS (Basic) 0.43 0.59 -27.1%
EPS (Diluted) 0.42 0.59 -28.8%
Wtd Avg Shares (Basic) -0.5 0.1 -600.0%
Wtd Avg Shares (Diluted) -0.6 0.1 -700.0%
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax -3.1 2.1 -247.6%

Balance Sheet

Balance Sheet
Metric Q4 2025 Q4 2024 YoY
Current Assets
Cash & Cash Equivalents 110.6 107.6 +2.8%
Accounts Receivable 829 717 +15.6%
Inventory 846 802.7 +5.4%
Prepaid Expenses & Other Current Assets 320.8 324.2 -1.0%
Total Current Assets 2,106.4 1,951.5 +7.9%
Non-Current Assets
Goodwill 3,853.4 3,838.4 +0.4%
Show Business Segments breakouts
CooperSurgical 2,043.4 2,040.6 +0.1%
CooperVision 1,810 1,797.8 +0.7%
Deferred Tax Assets 2,077.5 2,210.3 -6.0%
Other Non-Current Assets 689.2 660.6 +4.3%
Total Assets 12,394.8 12,315.2 +0.6%
Show Business Segments breakouts
CooperSurgical · Operating Segments 4,619.3 4,832 -4.4%
CooperVision · Operating Segments 7,604.4 7,285.1 +4.4%
Show Consolidation Items breakouts
Corporate Non Segment 171.1 198.1 -13.6%
Property, Plant & Equipment 2,079.9 1,860.5 +11.8%
Operating Lease Right-of-Use Assets 270.9 260.7 +3.9%
Intangible Assets 1,585.2 1,789.2 -11.4%
Other Assets
Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization 2,082 1,863.4 +11.7%
Show Geography breakouts
Europe · Reportable Geographical Components 429.1 401.7 +6.8%
Rest of World · Eliminations, Corporate and Reconciling Items 263.5 272.9 -3.4%
US · Reportable Geographical Components 1,389.4 1,188.8 +16.9%
Intangible Assets Net Excluding Goodwill 1,586.3 1,791 -11.4%
Current Liabilities
Debt Current 47.8 33.3 +43.5%
Accounts Payable 300.4 260.5 +15.3%
Employee Related Liabilities Current 210.6 174.8 +20.5%
Deferred Revenue (Current) 127.9 129.9 -1.5%
Other Liabilities Current 426.1 424.3 +0.4%
Total Current Liabilities 1,112.8 1,022.8 +8.8%
Non-Current Liabilities
Deferred Tax Liabilities 93.3 96 -2.8%
Accrued Income Taxes Noncurrent 7.5 57.5 -87.0%
Contract With Customer Liability Noncurrent 201.8 193.3 +4.4%
Other Non-Current Liabilities 282.8 311.6 -9.2%
Total Liabilities 4,155.7 4,231.6 -1.8%
Long-Term Debt 2,455.7 2,548 -3.6%
Operating Lease Liabilities 240.5 230.8 +4.2%
Other Liabilities
Long Term Debt And Capital Lease Obligations 2,457.5 2,550.4 -3.6%
Stockholders' Equity
Common Stock 21.8 21.7 +0.5%
Additional Paid-In Capital 1,975.5 1,921 +2.8%
Accumulated Other Comprehensive Income -406.5 -421.7 +3.6%
Retained Earnings 7,643.3 7,268.4 +5.2%
Treasury Stock Common Value -995.2 -706 -41.0%
Total Stockholders' Equity 8,238.9 8,083.4 +1.9%
Minority Interest 0.2 0.2 0.0%
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 8,239.1 8,083.6 +1.9%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment 1.7 -4.9 +134.7%
Accumulated Gain (Loss), Net, Cash Flow Hedge, Before Tax, Parent 23.7 59.2 -60.0%
Accumulated Gain Loss Net Cash Flow Hedge Parent 18 44.9 -59.9%
Accumulated Other Comprehensive Income -406.5 -421.7 +3.6%
Accumulated Translation Adjustment -426.2 -461.7 +7.7%
Additional Paid In Capital 1,975.5 1,921 +2.8%
Common Shares 20 19.9 +0.5%
Noncontrolling Interest 0.2 0.2 0.0%
Retained Earnings 7,643.3 7,268.4 +5.2%
Treasury Stock 1.8 1.8 0.0%
Treasury Stock Common -995.2 -706 -41.0%
Total Liabilities & Equity 12,394.8 12,315.2 +0.6%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q4 2025 YTD Q4 2024 YoY
Operating Activities
Depreciation & Amortization 98.4 91 +8.1%
Deferred Income Taxes 13 22 -40.9%
Net Cash from Operations 247.9 268.1 -7.5%
Investing Activities
Capital Expenditures -98 -140 +30.0%
Payments To Acquire Businesses And Assets Net Of Cash Acquired And Other -0.8 -101.6 +99.2%
Net Cash from Investing -98.8 -241.6 +59.1%
Financing Activities
Proceeds From Issuance Of Long Term Debt 936.2 716.4 +30.7%
Repayments Of Long Term Debt -910.5 -757.6 -20.2%
Proceeds From Repayments Of Short Term Debt 2.3 -8.4 +127.4%
Proceeds From Stock Plans 4.1 2.4 +70.8%
Net Cash from Financing -164.4 -28.4 -478.9%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 1 -0.2 +600.0%
Net Change in Cash -14.3 -2.1 -581.0%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 110.6 107.7 +2.7%

Values in millions USD. Source: SEC EDGAR 10-K filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key